Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece

BACKGROUND: To evaluate the long-term cost-effectiveness of liraglutide versus sitagliptin or exenatide, added to oral antidiabetic drug mono- or combination therapy respectively, in patients with Type 2 diabetes in Greece. METHODS: The CORE Diabetes Model, a validated computer simulation model, was...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tzanetakos, Charalampos, Melidonis, Andreas, Verras, Christos, Kourlaba, Georgia, Maniadakis, Nikos
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179852/
https://ncbi.nlm.nih.gov/pubmed/25245666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-14-419
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky